You are here: Industry Insights > prostate cancer

News List

Nubeqa authorised in Europe for certain prostate cancer patients pharmatimes
April 01, 2020
The European Commission has granted marketing authorisation in the European Union (EU) for Bayer’s Nubeqa (darolutamide).
Increasing Vegetable Intake Does Not Slow Prostate Cancer drugs
January 17, 2020
A behavioral intervention that increases vegetable consumption does not reduce the risk for progression of early-stage prostate cancer, according to a study published in the January issue of the Journal of the American Medical Association.
AI Might Help Spot, Evaluate Prostate Cancer drugs
January 17, 2020
In another step toward using artificial intelligence in medicine, a new study shows that computers can be trained to match human experts in judging the severity of prostate tumors.
FDA grants Clovis’ Rubraca fast track designation for prostate cancer pharmaceutical-technology
January 17, 2020
Colorado-based Clovis Oncology has received fast track designation from the US Food and Drug Administration (FDA) for Rubraca (rucaparib) as a monotherapy for BRCA1/2-mutant recurrent, metastatic castrate-resistant prostate cancer (mCRPC) adult patients.
AI System Can Detect, Grade Cancer in Prostate Needle Biopsy drugs
January 16, 2020
An artificial intelligence (AI) system can be used to detect and grade prostate cancer in prostate needle biopsy samples, according to a study published online January in The Lancet Oncology.
Nuclear radiologists 'outsmart' prostate cancer with an apparently ineffective drug worldpharmanews
January 14, 2020
When a non-scientist tries to imagine a scientist, the image that often arises is one of a somewhat remote, rather idealistic genius sitting alone in their room or laboratory and somehow discovering the most amazing things without every having contact wit
Risk-Based Approach Could Help Target Prostate Cancer Screening drugs
December 30, 2019
Risk-tailored screening could potentially reduce overdiagnosis and improve the cost-effectiveness of a prostate cancer screening program, according to a study published online December in PLOS Medicine.
Organ Transplant Does Not Worsen Prostate Cancer Outcome drugs
December 26, 2019
Among older men with prostate cancer, an organ transplant is associated with higher overall mortality, but not prostate cancer-specific mortality (PCSM)
Farrer Park Hospital Implements Non-Invasive Treatment for Prostate Cancer Patients in Singapore En-CPhI.CN
December 10, 2019
Farrer Park Hospital is pleased to announce that it is the first in South East Asia to have implemented the Focal One® High-Intensity Frequency Ultrasound (HIFU) Robotic Technology ...
Olaparib becomes first gene-targeted medicine to show benefits in prostate cancer worldpharmanews
December 10, 2019
A pioneering precision medicine already licensed for breast and ovarian cancer can also slow or stop tumour growth in some men with advanced prostate cancer ...

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page